Cancer risk in patients with monoclonal gammopathy of undetermined significance
Open Access
- 14 December 1999
- journal article
- Published by Wiley in American Journal of Hematology
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The Natural History of Monoclonal Gammopathy of Undetermined SignificanceActa Haematologica, 1997
- 4Monoclonal gammopathy of undetermined significance (MGUS)Bailliere's Clinical Haematology, 1995
- “Benign” Monoclonal Gammopathy—After 20 to 35 Years of Follow-UpMayo Clinic Proceedings, 1993
- Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significanceBritish Journal of Haematology, 1992
- Benign monoclonal gammopathy: a reassessment of the problemImmunological Investigations, 1985
- Monoclonal gammopathies in the adult population of Finistère, France.Journal of Clinical Pathology, 1982
- Homogeneous (monoclonal) immunoglobulins in cancerThe American Journal of Medicine, 1977
- Studies of “Benign” Serum M-ComponentsThe Lancet Healthy Longevity, 1969
- Monoclonal gammopathy in human neoplasiaCancer, 1968
- Frequency of Pathological Proteins (M‐components) in 6,995 Sera from an Adult PopulationActa Medica Scandinavica, 1966